- Home
- CEG vs GSK Comparison
CEG vs GSK Comparison
Compare CEG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEG
- GSK
- Stock Information
- Founded
- CEG 1999
- GSK 1715
- Country
- CEG United States
- GSK United Kingdom
- Employees
- CEG N/A
- GSK N/A
- Industry
- CEG Electric Utilities: Central
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- CEG Utilities
- GSK Health Care
- Exchange
- CEG Nasdaq
- GSK Nasdaq
- Market Cap
- CEG 108.2B
- GSK 77.1B
- IPO Year
- CEG N/A
- GSK N/A
- Fundamental
- Price
- CEG $330.42
- GSK $40.30
- Analyst Decision
- CEG Buy
- GSK Hold
- Analyst Count
- CEG 15
- GSK 2
- Target Price
- CEG $342.07
- GSK N/A
- AVG Volume (30 Days)
- CEG 2.0M
- GSK 3.7M
- Earning Date
- CEG 11-03-2025
- GSK 10-29-2025
- Dividend Yield
- CEG 0.47%
- GSK 4.02%
- EPS Growth
- CEG 27.80
- GSK N/A
- EPS
- CEG 9.58
- GSK 1.13
- Revenue
- CEG $24,820,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- CEG $2.21
- GSK $5.66
- Revenue Next Year
- CEG $2.49
- GSK $5.13
- P/E Ratio
- CEG $34.50
- GSK $35.58
- Revenue Growth
- CEG 5.42
- GSK 0.59
- 52 Week Low
- CEG $161.35
- GSK $31.72
- 52 Week High
- CEG $357.00
- GSK $43.62
- Technical
- Relative Strength Index (RSI)
- CEG 60.32
- GSK 54.63
- Support Level
- CEG $315.28
- GSK $39.37
- Resistance Level
- CEG $328.30
- GSK $41.53
- Average True Range (ATR)
- CEG 9.88
- GSK 0.60
- MACD
- CEG 2.34
- GSK 0.05
- Stochastic Oscillator
- CEG 89.35
- GSK 57.59
About CEG Constellation Energy Corporation
Constellation Energy Corp producer of carbon-free energy and a supplier of energy products and services. The company offers generating capacity that includes nuclear, wind, solar, natural gas, and hydroelectric assets. It sells electricity, natural gas, and other energy-related products and sustainable solutions to various types of customers, including distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers in markets across multiple geographic regions. Its operating segments and reporting units are Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.